TheBrief.Health

Motif Neurotech Gets FDA IDE To Study Brain Implant In Depression

Episode Summary

Motif Neurotech’s implantable depression device may expand treatment options through minimally invasive brain stimulation, offering personalized at-home therapy for patients with treatment-resistant depression.